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Abstract
Background: Chromosome band 10q24 is a gene-rich domain and host to a number of cancer,
developmental, and neurological genes. Recurring translocations, deletions and mutations involving
this chromosome band have been observed in different human cancers and other disease
conditions, but the precise identification of breakpoint sites, and detailed characterization of the
genetic basis and mechanisms which underlie many of these rearrangements has yet to be resolved.
Towards this end it is vital to establish a definitive genetic map of this region, which to date has
shown considerable volatility through time in published works of scientific journals, within different
builds of the same international genomic database, and across the differently constructed databases.
Results: Using a combination of chromosome and interphase fluorescent in situ hybridization
(FISH), BAC end-sequencing and genomic database analysis we present a physical map showing that
the order and chromosomal orientation of selected genes within 10q24 is CEN-CYP2C9-PAX2-
HOX11-NFKB2-TEL. Our analysis has resolved the orientation of an otherwise dynamically evolving
assembly of larger contigs upstream of this region, and in so doing verifies the order and orientation
of a further 9 cancer-related genes and GOT1. This study further shows that the previously
reported human papillomavirus type 6a DNA integration site HPV6AI1 does not map to 10q24, but
that it maps at the interface of chromosome bands 14q13.3-q21.1.
Conclusions:  This revised map will allow more precise localization of chromosome
rearrangements involving chromosome band 10q24, and will serve as a useful baseline to better
understand the molecular aetiology of chromosomal instability in this region. In particular, the
relocation of HPV6AI1 is important to report because this HPV6a integration site, originally
isolated from a tonsillar carcinoma, was shown to be rearranged in other HPV6a-related
Published: 3 March 2003
BMC Genomics 2003, 4:9
Received: 26 November 2002
Accepted: 3 March 2003
This article is available from: http://www.biomedcentral.com/1471-2164/4/9
© 2003 Gough et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/9
Page 2 of 12
(page number not for citation purposes)
malignancies, including 2 of 25 genital condylomas, and 2 of 7 head and neck tumors tested. Our
finding shifts the focus of this genomic interest from 10q24 to the chromosome 14 site.
Background
The genomic interval that spans chromosome bands
10q24-q25 contains a high frequency of structural chro-
mosome aberrations associated with cancer and develop-
ment. However, existing published maps around the
PAX2/HOX11/NFKB2 region of 10q24 have differed with
respect to marker and gene content, their relative order
and chromosomal orientation [1–4]. More recent incon-
sistencies in the positioning of selected genes with respect
to known markers have also been evident within the con-
text of the human genome databases (Figure 1). It is essen-
tial to have available an accurate physical map of this
region so that disease-related chromosome aberrations
can be precisely localized, and to better understand the in-
terplay of regulatory elements associated with genes that
map within this domain.
The 10q24 region harbors several loci of fundamental bi-
ological importance, including the HOX11 (TLX1,TCL3),
PAX2  and  NFKB2/LYT-10  genes.  HOX11  is an orphan
homeobox gene that maps outside of the four recognized
homeobox gene clusters. It encodes a DNA-binding nucle-
ar transcription factor [5], and is involved in spleen orga-
nogenesis [6,7]. About 5% of T-cell acute lymphoblastic
leukaemias (T-ALL) show chromosome translocations in-
volving break-prone regions immediately upstream of the
HOX11  gene at 10q24 and the TCR genes at 7q35 or
14q11. HOX11  is activated by TCR α/δ regulatory ele-
ments as a result of these rearrangements, and inappropri-
ately expresses a 2.3 kb transcript [8–13]. PAX2  is
important during embryogenesis, and is aberrantly ex-
pressed in renal, breast and prostate tumors [14–16]. Mu-
tations in PAX2 are also associated with defects in eye, ear,
urogenital tract and CNS development [17,18]. The nucle-
ar factor kappa-B 2 (NFKB2) gene is a member of the
NFKB/Rel gene family, the signaling pathways of which
are recognized as pivotal to the regulation of acute inflam-
matory and immune responses, and increasingly to tumor
development [19,20]. Translocations or structural altera-
tions of NFKB2 (alias LYT-10) have been associated with
~2% of various lymphoid malignancies, and usually result
in the partial or total deletion of the carboxyl-terminal re-
gion encoding the ankyrin domain [21,22].
Positional cloning of a balanced t(10;19)(q24;q13) trans-
location found in a glioblastoma cell line has identified a
new gene, LGI1, which is rearranged and downregulated
in malignant brain tumors and has recently been implicat-
ed in autosomal dominant lateral temporal epilepsy
(EPT) [23–25]. Karyotype, comparative genomic hybridi-
zation and loss of heterozygosity studies also indicate that
yet to be identified oncogenes or tumor suppressor genes
map to 10q24. For example, loss or rearrangement of re-
gions encompassing 10q24 is associated with cancers of
the lung [26,27], prostate [28–33], bladder [34–36], skin
[37,38], and lymphatic system [39–41]. The human pap-
illomavirus type 6a (HPV6a) was also previously reported
to integrate at 10q24 in a case of tonsillar carcinoma, and
rearrangements involving this locus have been indicated
for other papillomavirus-associated malignancies [42].
As one part of our investigations of a novel leukaemia-re-
lated chromosomal translocation (Gough et al, unpub-
lished), we have used a combination of chromosome and
interphase FISH, BAC end-sequencing, PCR and genome
database analysis to map the order and chromosomal ori-
entation of selected cancer-related genes and the HPV6a
viral integration site HPV6AI1 within 10q24. Here we
present new data that confirms the order CEN-CYP2C9-
PAX2-HOX11-NFKB2-TEL. This finding resolves the phys-
ical arrangement of larger DNA sequence contigs contain-
ing these and at least 9 other genes which have so far been
implicated in different cancer subtypes. Our studies fur-
ther show that HPV6AI1 does not map within 10q24, but
at a different chromosomal site, namely at the interface of
chromosome bands 14q13.3-q21.1.
Results
Two-Color FISH Establishes Order and Orientation of 
Genes and Markers at 10q24
Selected large-insert clones (refer Methods) were biotin-
or digoxygenin-labeled, pooled in combinations of three,
then hybridized to G1-arrested interphase nuclei. For each
experiment, after signal amplification using FITC- (green)
or Texas Red- (red) tagged immunofluorescent reagents,
the order of signals from at least 55 chromosomes, and
usually 100, was recorded. After exclusion of chromo-
somes showing ambiguous signal patterns, the predomi-
nant order of signals was taken to represent the physical
order of the probes along the chromosome (Table 1, Fig-
ure 2a,2b,2c,2d,2e,2f,2g,2h,2i,2j,2k,2l). For many combi-
nations, the same three probes were pooled and
hybridized twice. For the first of these paired experiments,
two probes were labeled with biotin and a third with dig-
oxygenin. For the second, the probe label and detection
color was reversed for two of the probes. By this alterna-
tion, and through a sequence of different probe combina-
tions, a final arrangement of genes and markers across the
10q24 region was derived (Table 1, Figures 1d,2).BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/9
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Figure 1
Order and chromosomal orientation of clones mapped by FISH in this study (D) aligned with integrated NCBI maps dynami-
cally changing through the time periods April 2001 (Build 22), August 2001 (Build 25), April 2002 (Build 29) and November 
2002 (Build 31) (A-D). Genes and sites relevant to reagents used in this study are shown in bold or in grey-filled boxes, and if 
not marked, were not found in that particular Build. Also indicated are key STS sites common between previously published 
maps of this region [1–4] (C,D). For A and B, only D10S571, D10S1266, LGI1, GOT1 and WNT8B are shown, in addition to 
markers relevant to the reagents of this study (if found) to illustrate major rearrangements of database contigs within this 
region through the different NCBI Builds. The locations of 7 additional cancer-related genes are indicated in C and D, with the 
relative locations of clones used in the present study shown aligned with the recently released Build 31 (D) (see Results for fur-
ther details). Arrowheads above maps B-D correspond to cancer-related chromosome breakpoint sites associated with dis-
ruption of the LGI1 gene [23,46], HOX11 [8–13] and NFKB2/LYT-10 [21,22]. The cancer-related gene MXI1[30] maps ~7.5 Mb 
telomeric of GERP1.
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Figure 2
Metaphase (c,j) and interphase (a,b,d-i,k,l) FISH analysis determines order and relative orientation of selected cancer-related 
gene probes within 10q24 (m). For interphase figures (a-l), locus identities are indicated in text beneath each representative 
image, with text color corresponding to the FISH detection color used. Observed frequencies (%) of the probe orders shown 
are also indicated. Note that the triangular pattern of probes visible on one homologue in a) was classified ambiguous.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/9
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BAC clones 10E3, 10D14 and 10D15 were each first hy-
bridized to normal metaphase chromosomes and con-
firmed to map to 10q24 (data not shown). Interphase
FISH experiments subsequently revealed the clone order
10D15-10D14-10E3 (Table 1, Figure 2a,2b). The chromo-
somal orientation of this map was determined when the
three pooled biotinylated BAC clones were shown to map
centromeric of the digoxygenylated YAC clone 29CD5
(PAX2) on the majority of metaphase chromosomes 10
analyzed (Figure 2c, left), and when BAC 10D15 was sim-
ilarly shown to map centromeric of BAC 165f21 (PAX2)
(Figure 2c, right). The final centromere-telomere orienta-
tion of the BAC clones relative to PAX2 was established
when BACs 10E3 and 10D14 were hybridized in combi-
nation with YAC 29CD5 (PAX2) or BAC 165f21 (PAX2) to
interphase nuclei in a series of three different experiments
(Table 1, Figure 2d,2e,2f). From this combined data we
concluded the preliminary map order centromere-10D15-
10D14-10E3-29CD5/165f21/PAX2-telomere.
The cosmid C2 (CosC2), reported to contain the HPV6a
viral integration site HPV6AI1[42], was next mapped with
respect to 10D14 and BAC 165f21(PAX2) (Table 1, Figure
2g,2h), indicating the order centromere-10D14-
165f21(PAX2)-CosC2-telomere (Figure 2m). HOX11 was
shown to map close and immediately telomeric of CosC2
when the λSh3F probe (green) was pooled with BAC
165f21 (green) and CosC2 (red), and hybridized to inter-
phase nuclei. This conclusion was based on the predomi-
nant green-red-green signal order for this experiment
(Table 1, Figure 2i), the already established centromeric
location of PAX2 relative to CosC2 (Figure 2g,2h), and the
smaller size of the λSh3F (HOX11) probe and signal (Fig-
ure 2i). We note that three cDNA fragments (EM-
BL:HSAPTB7, EBML:HSAPTL12, EMBL:HSAPTF3) have
been isolated from CosC2 and sequenced (NCBI Acces-
sion Nos Y11608, Y11609, and Y11610) (Kahn et al, un-
published). Consistent with the above interphase FISH
results, BLASTN and Map Viewer http://www.nc-
bi.nlm.nih.gov/mapview/map_search.cgi? analysis con-
firmed that all of these cDNA fragments map immediately
centromeric of HOX11 in NCBI Build 31.
The NFKB2/LYT-10 locus represented by the probe λlyt-10
mapped telomeric of 10D14 and CosC2 in two interphase
experiments, with the second experiment alternating the
CosC2 probe label (Table 1, Figure 2k,2l,2m). A final hy-
bridization of pooled biotinylated and digoxygenylated
λlyt-10 probe (yellow) with λPAX2 (red) and λSh3F
(HOX11) (green) to interphase nuclei determined the or-
der red-green-yellow on 24 of 32 (75%) chromosomes
analyzed (data not shown), and confirmed that NFKB2/
LYT-10 mapped telomeric of HOX11.
The final overall map orientation was confirmed when
λlyt-10 (green) was shown to hybridize telomeric of BAC
10D15 (red) (Figure 2j) on metaphase chromosomes, and
although not measured statistically, the distance
separating 10D15 and λlyt-10 was visibly greater than that
which separates 10D15 and BAC 165f21 (PAX2) (com-
pare Figure 2c,2j). From these metaphase and interphase
FISH studies, we determined the following probe (gene)
order within 10q24: centromere-10D15-10D14-10E3-
YAC29CD5/BAC165f21(PAX2)-CosC2-λSh3F(HOX11)-
λlyt-10 (NFKB2) -telomere (Figure 1d, 2m).
Chromosome 10 clone CosC2 does not contain the human 
papillomavirus integration site HPV6AI1 which instead 
maps to chromosome 14
The close proximity of CosC2 and λSh3F (HOX11)
probes, indicated by a high percentage of overlapping red
and green signals (Figure 2i and data not shown), was
Table 1: Order and Frequency of Probe Signal Patterns on Interphase Nuclei after FISH
Probe Combination (Detection Color1) Signal Order [No. scored (%)]
Red-Gr-Red Red-Red-Gr Red-Gr-Gr Gr-Red-Gr
10D15b(R) + 10D14d (Gr) + 10E3b (R) 38 (69%) 17 (31%)
10D15b(R) + 10D14b (R) + 10E3d (Gr) 23 (26%) 66 (74%)
10D14b (R) + 10E3d (Gr) + 29CD5 (PAX2)d (Gr) 75 (99%) 1 (1%)
10D14d (Gr) + 10E3b (R) + 29CD5 (PAX2)d (Gr) 25 (30%) 58 (70%)
10D14d (Gr) + 10E3d (Gr) + 165f21 (PAX2)b (R) 67 (75%) 22 (25%)
10D14b (R) + 165f21 (PAX2)b (R) + CosC2d (Gr) 13 (18%) 61 (82%)
10D14b (R) + 165f21 (PAX2)d (Gr) + CosC2d (Gr) 79 (95%) 4 (5%)
165f21 (PAX2)d (Gr) + CosC2b (R) + λSh3F (HOX11)d (Gr) 7 (18%) 32 (82%)
10D14b (R) + CosC2d (Gr) + λlyt-10 (LYT-10)d (Gr) 76 (82%) 17 (18%)
10D14b (R) + CosC2b (R) + λlyt-10 (LYT-10)d (Gr) 22 (25%) 67 (75%)
1R, red; Gr, Green; b Biotin labelled. d Digoxygenin labelled. Probe combinations represented correspond to Figures 2a,2b,2d,2e,2f,2g,2h,2i,2k and 
2l, respectively.BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/9
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noteworthy in this analysis and suggested that the
HPV6AI1 integration site (CosC2) maps closely centro-
meric and probably <200 kb of HOX11 [43,44]. However,
genomic database investigations indicated that the 2746
bp of genomic sequence available across HPV6AI1 (NCBI
Accession No_X77607; [42]), and that was originally re-
ported to derive from a BamHI-BglII subclone of CosC2, is
not tightly integrated within 10q24 contigs of the
genomic databases (eg. NCBI Map View, Build 31, No-
vember, 2002), but instead finds significant, if disrupted,
homology across nts 1..2341 (98%) and 2334..2735
(94%) to chromosome 14, at the q13.3-q21.1 band inter-
face (NCBI Accession No NT_026437.9, Build 31) (Figure
3c). Restriction digests of CosC2 released fragment sizes
consistent with reported features of that clone [42] (data
not shown), and internal Alu-specific primers A51 (for-
ward) and Sb2ins2 (reverse) confirmed the integrity of
CosC2 DNA (Figure 3a, left panel, lanes 4–6). However,
three PCR primer pairs that were designed to distinguish
closely homologous chromosome 14 sequences from
those theoretically on 10q24 (Table 2) failed to amplify
products from CosC2 under relaxed primer annealing
conditions (52°C, 2 mM Mg++) (Figure 3a, right panel,
lanes 4–6), but did so from control genomic DNA (Figure
3a, right panel, lanes 1–3). Primer pair A (HPV6apr1/
HPV6aRev) amplifies a 615 bp product common to both
X77607 and homologous chromosome 14 sequence (Fig-
ure 3a,3c). Primer pairs B (Chr14gapF/Chr14gapR) and C
(Chr14endF/Chr14endR) were designed to amplify 535
bp and 699 bp products specific to chromosome 14 se-
quence as determined by genomic database comparisons
(Figure 3a,3c). When hybridized to a Southern-blotted
human chromosome-specific somatic cell hybrid panel,
the 615 bp fragment showed positive signals only in the
control and chromosome 14-specific lanes (Figure 3b).
From these studies we conclude that CosC2 does not con-
tain the 2746 bp viral integration site HPV6AI1 of NCBI
Accession X77607, but that this site instead maps to the
chromosome band 14q13.3-q21.1 interface. We are una-
ble to explain the 209 bp of sequence that is present on
chromosome 14q but not in X77607 (Figure 3c). The
chromosome 14 "insertion" occurs within a L1PREC2
nontransposable repeat element, and may correspond to
an insertion/deletion polymorphism although sequence
artifact cannot be excluded.
BAC End Sequencing Allows Integration of FISH Results 
into Genomic 10q24 Map
To facilitate the orientation and relative locations of
probes used for FISH studies, T7-primed genomic end-se-
quences of BAC clones 10D14, 10D15 and 10E3 were
submitted to BLASTN after identification of repetitive se-
quences using CENSOR. In the sequence release of Build
31 (November 2002), a 520 bp end-sequence of 10D15
showed 95% homology across nucleotides (nts)
11626039–11626469 of NCBI contig NT_033890.3 (Fig-
ure 1d), consistent with its most centromeric location in
our study (Figure 1d). A 700 bp end-sequence of 10D14
showed 98% homology across nts 8367245–8367938 to-
wards the telomeric end of the same contig as 10D15 in
Build 29, mapping ~650 bp upstream of the 5' start of the
cytochrome P4502C9 (CYP2C9) gene (Figure 1c and data
not shown). In Build 31, end-sequences of 10D15 and
10D14 (NT_030059.8, nts 1961641–1962337) have
been mapped to different juxtaposing contigs. The spatial
and chromosomal orientation of 10D15 and 10D14
through these two Builds is, however, consistent with our
FISH interphase mapping results, which show that
CYP2C9 maps centromeric of the PAX2/HOX11/NFKB2
region (Figure 1d). Finally, a 650 bp end-sequence of
10E3 showed 99% homology across nts 12098591–
12097943 of contig NT_030059.6 in Build 29 (Figure 1c).
This location is inconsistent with the visibly centromeric
location and closer proximity of 10E3 to PAX2  (YAC
29CD5/BAC 165f21) in interphase FISH experiments
(Figure 2c,2d,2e), a finding that is more consistent with
the relocation in Build 31 of contig NT_030059.8 which
contains the 10E3 homologous nts 6881174–6881822
(Figure 1d).
Alignment of BACs 10D14, 10D15 and 10E3 end-se-
quences against 10q24 contigs of earlier NCBI Builds 22
(April 2001), 25 (August 2001) and 29 (April 2002)
graphically reflects the dynamically evolving assembly of
contigs, genes and markers within this region (compare
Figures 1a,1b,1c). Our FISH interphase mapping and
BAC-end sequencing results fitted best into the current
NCBI sequence contigs (NCBI Build 31) (Figure 1d), and
is also in agreement with the Human Genome Project
Working Draft http://genome.ucsc.edu/ described by the
International Human Genome Sequencing Consortium
[45]. The relative locations of 9 other genes reported to be
structurally or functionally implicated in malignancy, in-
cluding LGI1 [23,46], FRAT1 [47], FRAT2 [48], WNT8B
[49], LAPSER1 [32], FGF8 [50], MGEA5 [51], SUFU [52]
and  GERP  (TRIM8) [53], the STS markers D10S583,
D10S571, D10S198, D10S603, D10S1266, D10S192,
D10S278, D10S1265 and the gene GOT1  were deter-
mined by BLASTN comparison of deposited sequences
against the NCBI databases (Figure 1c,1d).
Discussion
Using interphase FISH we have determined the relative or-
der of selected cancer-related genes that map within chro-
mosome band 10q24. This analysis, complemented by
BAC end-sequencing and genomic database analysis, has
also established the chromosomal orientation of NCBI
nucleotide contigs that contain these genes, and which
span ~11 Mb. The gene and marker order that we have de-
termined is centromere-BAC10D15-BAC10D14/CYP2C9-BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/9
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Figure 3
PCR confirms absence of the HPV6AI1 site in the recombinant cosmid clone CosC2. (A) Gel electrophoresis of products 
amplified from human genomic DNA and CosC2 DNA using PCR primer sets A, B and C, and Alu-specific primers (refer Fig-
ure 3C, Table 2). In the left panel, lanes 1–3 show genomic DNA fragments amplified with primer sets A (615 bp product), B 
(535 bp product), and C (699 bp product), all at 1.5 mM Mg++ and annealed at 60°C. Lane 4 shows CosC2 DNA amplified 
with Alu primers A51/Sb2ins2. Lanes 5 and 6 are, respectively, negative (no DNA) and positive genomic DNA controls for this 
primer set. Lane N is a negative control (no DNA) for primer set A. In the right panel, lanes 1–3 are as in the left panel except 
that reactions were at 2 mM Mg++ with annealing at 52°C. Note the presence of additional bands in lane 3 under these relaxed 
stringency PCR conditions. Lanes 4–6, under the same conditions, show no product from the CosC2 template using the prim-
ers sets A, B and C respectively. In both left and right panels, M is a 100 bp molecular weight reference ladder. (B) Somatic cell 
hybrid panel showing PstI fragments of ~9.5 kb detected in control male and female genomic DNA lanes, and in the chromo-
some 14 specific lane (arrow) after hybridization with the 32P-dCTP labeled 615 bp fragment amplified using primer set A. λ 
HindIII fragment sizes are indicated to the left of the panel. (C) Alignment of the published sequence X77607 with contig 
NT_026437.9 from chromosome (chr) 14. In the lower figure, the thin grey line corresponds to chr 14 sequence, and thicker 
solid (repeat-free) or hatched boxes correspond to regions that have overlapping homology with X77607. Repeat sequences 
identified using CENSOR are shown as diagonal hatched regions corresponding to CHESHIRE_B (narrow downward), LIPB4 
(wide upward), L1PREC2 (narrow upward) and THE1B (wide downward). Flanking nt sequence locations are indicated for each 
contig, as is the location of the HPV6AI1 integration site. Locations of primer pairs A-C are marked by forward (f) and reverse 
(r) arrows. The bracketed region marks 209 bp of chr 14 sequence not present in X77607.
C
A B
HPV6AI1 
integration site
Chr 14 – NT_026437.9
1
Br Cr
209bp gap 
X77607 – HPV6AI1
2735 Af
Bf Cf
Ar
6733610 6736577
CEN TEL
1252
6734863
22 2021 16171819 12131415 9 81 0 1 1 67 5 4 3 2 1
M
a
l
e
F
e
m
a
l
e
M
o
u
s
e
H
a
m
s
t
e
r
XY
23130
9419
6557
4371
λ
H
i
n
d
 
I
I
I
λ
H
i
n
d
 
I
I
I
Human Chromosome #
123456 M
100
800
600
300
Genomic Cos C2
N 6 5 4 3 2M 1
Genomic Cos C2BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/9
Page 8 of 12
(page number not for citation purposes)
BAC10E3-PAX2-CosC2-HOX11-NFKB2/LYT-10-tel-
omere. The order of genes and markers on our map differs
from the NCBI release of Build 29, and is more consistent
with previous NCBI releases including Build 25, with the
June 2002 freeze of the UCSC Human Genome Project
Working Draft http://genome.ucsc.edu/ and with the
more recently released NCBI Build 31.
There have been several published studies designed to
clarify the physical map across 10q24 [1], although none
have specifically focussed on the order and orientation of
cancer-related genes or sites of inter- and intra-chromo-
somal rearrangement involving this region. In one of
these reports, Gray et al applied a combination of met-
aphase FISH (to confirm 10q24 map location) and PCR
amplification of microsatellite, STS and other known gene
markers to the analysis of a series of overlapping YACs
spanning ~15 Mb of DNA [1]. Of particular interest, Gray
et al noted a high frequency of rearranged YACs (4/5 ana-
lysed) distal to D10S574 and incorporating the GOT1,
WNT8B and PAX2 gene cluster. That feature, combined
with the inability to isolate YAC clones immediately telo-
meric of this region, a known BrdU-inducible fragile site
in 10q24-q25, and chromosome translocation breakpoint
clusters associated with ALL and other
lymphoproliferative neoplasms is suggestive of inherent
instability of this chromosomal segment [1]. To date, al-
though chromosomal imbalances involving this region
are prevalent across a wide variety of different cancer
subtypes, the genomic basis for this instability has yet to
be explained.
In the separate study of Nikali and colleagues, which was
designed to refine the map location of the IOSCA locus at
10q24, a similar map configuration was derived [2]. For
this study, radiation hybrid analysis was used to deter-
mine the order of selected microsatellite and other known
STS or gene markers, including PAX2, across a >500 kb re-
gion between D10S198 and D10S222 [2]. Fibre-FISH was
also used to confirm the order and orientation of selected
clones within the IOSCA region but did not confirm chro-
mosomal orientation of the contig under study [2].
Neither of the above two studies, nor others reported sub-
sequently [4,54–56], have provided unequivocal evidence
of the centromere-telomere orientation of PAX2, HOX11
and NFKB2/LYT-10 within the 10q24 region that we have
targeted. Nor do they include analyses that convincingly
demonstrate the relative location of these and other can-
cer-related genes across this region. Most published inves-
tigations to date have used YAC clones and microsatellite
analysis to map the 10q24 region, or have referenced
maps constructed with YACs. However, the reported
propensity for YACs derived from this region to undergo
internal rearrangement and deletions may have contribut-
ed to map inconsistencies. The information we have pre-
sented is based mostly on smaller insert BAC, cosmid and
bacteriophage clones. Our clarification of the 10q24 phys-
ical map is complementary to the International Human
Genome Sequencing Consortium BAC-derived assem-
blies hosted by the NCBI, and will enable more precise
mapping of chromosome translocation breakpoints or
other structural rearrangements associated with malig-
nant and nonmalignant disease conditions.
Our FISH studies show that the cosmid clone CosC2 maps
close, centromeric and upstream of the homeobox gene
HOX11. This finding was of interest because CosC2 re-
portedly contains the HPV6a viral integration site
HPV6AI1 previously associated with an infiltrating squa-
mous cell carcinoma of the tonsil [42], and suggested that
deregulation of HOX11 by the integration process may
have been implicated in this malignancy. However, ge-
nomic database analysis of sequences that did not derive
specifically from the germline CosC2 insert but which di-
rectly flank the previously described HPV6a integration
site indicates that HPV6AI1 maps not to 10q24 but to the
interface of chromosome band 14q13.3-q21.1. Further
database analysis showed that HPV6a integration oc-
curred within a L1PB4 nontransposable repeat, and be-
Table 2: PCR primer sequences and reaction conditions used to verify localization of HPV6AI1
Primer ID Locus Primer Sequence (5' > 3')a
Annealing Temp (°C) Mg++ (mM) Primer Pair IDb
HPV6apr1 HPV6AI1c F-TTATAGATTCGGGGGTACACACGTAG 60 1.5 A
HPV6aRev HPV6AI1c R-AGCAGAGAAAAGGAATGCCGATAT 60 1.5
Chr14gapF 14q13d F-TCTTGTTAAATTGTTTGAGTTCC 60 1.5 B
Chr14gapR 14q13d R-CTATTCTAATCAAAACAGCATGG 60 1.5
Chr14endF 14q13d F-TATTGAATAGAGAGTCCTTTCCC 60 1.5 C
Chr14endR 14q13d R-TAAACCTCATCTTGAATTGTAGC 60 1.5
A51 Alue F-GGCGCGGTGGCTCACG 65 1.5 Alu
Sb2ins2 Alu Sb2f R-GGCCGGACTGCGGACTGCA 65 1.5
a, F = forward, R = reverse; b, as represented in Figure 3; c,d derived from NCBI Accession No X77607 and NT_025892.8, respectively; e,f derived 
from Alu-repeat consensus and AluYb8 (Sb2) subfamily-specific consensus sequences, respectively (Labuda et al, unpublished).BMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/9
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tween the predicted coding domains of FLJ30803 and
LOC122529 (data not shown). This location was con-
firmed by subsequent PCR and somatic cell hybrid inves-
tigations. We presume that the cosmid clone C2 was
spuriously selected during the original screening process,
for which a probe derived from the sequenced region
X77607 was used [42].
The human papillomaviruses (HPVs) are a diverse family
that type-specifically infects distinct subsets of epithelial
cells. The HPV genome persists as an extrachromosomal
episome in non- or premalignant tissues, whereas in inva-
sive cancers, the viral DNA typically integrates into the
host genome. This event has been shown to increase sta-
bility of HPV16 E6 and E7 mRNAs [57]. Recent evidence
suggests that HPV integration sites associated with malig-
nancy are distributed widely across the human genome
rather than preferentially localized [58–60]. However,
there is a recognized propensity for HPV DNA integration
to occur in or near fragile sites, translocation breakpoint
sites, oncogenes or the coding regions of as yet poorly
characterized genes that may have relevance to cancer pro-
gression [59–65]. Although HPV6AI1 does not appear to
interrupt a coding domain, it is of interest that the
HPV6AI1 site falls within a repeat element and close to a
possible insertion/deletion polymorphism site on chro-
mosome 14. These findings are consistent with the highly
recombinogenic/unstable regions in which papillomavi-
rus integrations are predicted to occur.
Previously published studies of the HPV6a integration site
we have relocalized showed that the corresponding nor-
mal allele was not present in the originally characterized
tonsillar carcinoma cells [42]. Rearrangements in the re-
gion of the HPV6a integration site were also implicated by
Southern blot analysis of a limited number of other tu-
mors, including 2 of 25 genital condylomas, and 2 (1 ton-
sillar, 1 hypopharnyx) of 7 head and neck tumors tested
[42]. Together, these findings were suggestive that the
HPV6a genome had disrupted a novel cancer-related gene
or gene regulatory region at 10q24. However, analyses re-
ported here indicate that this site instead maps to
14q13.3-q21.1, and that loci FLJ30803 and LOC122529
may be two such candidate genes. Further investigations
of the chromosome 14 integration site are necessary to
verify its functional relevance to HPV-related
malignancies.
Conclusions
We have applied chromosome and interphase fluorescent
in situ hybridization (FISH), BAC end-sequencing, PCR
and genome database analysis to map the order and chro-
mosomal orientation of selected cancer-related genes
within chromosome band 10q24, and the human papil-
lomavirus Type 6a (HPV6a) viral integration site
HPV6AI1. The 10q24 region is already known to harbor
several well studied cancer-related genes, but published
cytogenetic, comparative genomic hybridization, allelo-
typing and other molecular studies suggest that yet to be
identified genes relevant to cancer initiation and progres-
sion map within this domain. Towards this end it is vital
to establish a definitive genetic map of this region, which
to date has shown considerable volatility through time in
published works of scientific journals, within different
builds of the same international genomic database, and
across the differently constructed databases. This volatility
has proved an ongoing frustration for positional cloning
efforts such as those we are pursuing, and it is for this rea-
son that we found the present study necessary. We de-
scribe new data that confirms the order CEN-CYP2C9-
PAX2-HOX11-NFKB2-TEL. This finding resolves the phys-
ical arrangement of larger DNA sequence contigs contain-
ing these and at least 10 other genes which have so far
been implicated in different cancer subtypes. Further-
more, our studies show that the viral integration site
HPV6AI1 does not map within 10q24, but at a different
chromosomal site, namely at the interface of chromo-
some bands 14q13.3-q21.1. This is a significant finding
and important to report because the HPV6AI1 integration
site, originally isolated from a tonsillar carcinoma, was
shown to be rearranged in other HPV6a-related
malignancies, including 2 of 25 genital condylomas, and
2 of 7 head and neck tumors tested (Kahn et al, 1994, Can-
cer Res. 54: 1305–1312). Our finding shifts the focus of
this genomic interest from 10q24 to a site on chromo-
some 14 that may potentially harbor a gene with an as yet
undetermined role in the etiology of carcinogenesis.
Methods
Genomic clones
Recombinant YAC, BAC and bacteriophage lambda
clones were used to determine the relative order and
orientation of the CYP2C9, NFKB2/LYT-10, HOX11 and
PAX2 gene loci, and the HPV6AI1 integration site. BAC
clones 10D15, 10D14 and 10E3 were selected from the
Cedars-Sinai Medical Center Genomic Reagents Resource
database http://www.csmc.edu/genetics/korenberg/int-
bac-sts.html based on their preliminary map location at
10q24 [66]. BAC clone 165f21, which contains the PAX2
gene, was kindly gifted by Dr K. Nikali (National Public
Health Institute, Helsinki, Finland), and YAC clone
29CD5 was isolated from the ICRF YAC library using PCR
primers specific for PAX2 (Eccles et al, unpublished). Ge-
nomic lambda (λ) clones of PAX2 (λPAX2) and HOX11
(λSh3F) were also isolated from a genomic liver library
constructed in λGem-11 (Promega, Madison, WI). Radio-
actively labelled probes used to screen the λ library as pre-
viously described were pG3a [67] and Sh3F [9] for PAX2
and HOX11, respectively. The phage clone λlyt-10 con-
tains a 12 kb genomic fragment including the entireBMC Genomics 2003, 4 http://www.biomedcentral.com/1471-2164/4/9
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NFKB2/LYT-10 coding sequence [68]. The previously de-
scribed cosmid clone CosC2 is reported to contain the vi-
ral integration site HPV6AI1 [42].
Fluorescent In Situ Hybridization (FISH)
Procedures used, including preparation of metaphase or
interphase nuclei from peripheral blood or G1 fibroblasts,
slide pre-treatment, probe labeling with biotin or digoxy-
genin, repeat suppression, hybridization parameters, and
single- or two-color immuno-fluorescent detection of la-
beled probes, were essentially as described [69,70]. Fluo-
rescent images from metaphase or interphase cells were
captured at selective bandwidths to computer using a
Leitz Aristoplan microscope fitted with a Photometrics
KAF1400 CCD camera and QUIPS Smartcapture software
(version 1.3; Vysis Inc, Downers Grove, IL, USA). Probes
were mapped precisely to chromosome bands in met-
aphase cells, or relative to each other in interphase cells,
using color-joined DAPI, FITC and Texas Red images, and
QUIPS CGH/Karyotyping software (version 3.0.2). To
avoid damaged cells, metaphase and G1 interphase nuclei
were initially selected for analysis under a DAPI-selective
filter. G1 interphase nuclei were subsequently scored only
if red or green signals corresponding to all probes hybrid-
ized were distinguishable on both homologues.
Polymerase Chain Reaction (PCR)
Primer sequences designed to amplify HPV6AI1, the ho-
mologous region on chromosome 14q and a control in-
ternal Alu-specific 260 bp fragment are as listed in Table
2. PCR reactions contained 100 ng of template DNA, 200
µM dNTPs, 500 nM of each primer, reaction buffer (50
mM KCl, 10 mM Tris pH 8.3, 1.5 or 2.0 mM MgCl2) and
0.5 units Platinum™ Taq DNA polymerase (Life Technol-
ogies). Following 30 cycles of amplification [denaturation
95°C, 30 sec; annealing (refer Table 2), 30 sec, extension
72°C, 30 sec], the PCR products were electrophoresed in
1.5% agarose gels and visualized by ethidium bromide
staining. Products were transferred to Hybond N+ nylon
membrane (Amersham, Buckinghamshire, UK) and hy-
bridized with Rediprime random-prime 32P-labeled
probes (Amersham) following the manufacturer's instruc-
tions. Control human genomic DNA for PCR studies was
extracted from healthy subjects using methods previously
described [71].
Somatic Cell Hybrid Analysis
A Southern blot containing PstI digested genomic DNA
from a human-rodent somatic cell hybrid panel was ob-
tained from Oncor (Gaithersburg, MD) and hybridized
with 32P-dCTP-labeled DNA fragments as outlined above.
BAC DNA End-Sequencing
End-sequencing of BAC clones 10D14, 10D15 and 10E3
(cloning vector pBAC108L; Shizuya et al., 1992) was per-
formed using ThermoSequenase (Amersham) and a uni-
versal T7 IRD41-labeled primer (MWG Biotech,
Germany) essentially according to the manufacturers rec-
ommendations. Reactions were separated on a LICOR
4000L semi-automated DNA sequencer, and nucleotide
sequences subsequently submitted to BLASTN for homol-
ogy determination.
Genomic Database Resources
Genomic database resources utilized early in this study in-
clude the GTC Integrated STS Map http://www.genom-
ecorp.com; http://ihg.gsf.de/chr10/
report_text.html#parti, the Southhampton Integrated
Map ftp://cedar.genetics.soton.ac.uk/pub/chrom10/
gmap, the Whitehead YAC contig WC10.8 http://www-ge-
nome.wi.mit.edu/cgi-bin/contig/lookup_contig and the
NCBI GeneMap 98 http://www.ncbi.nlm.nih.gov/
genemap98/map.cgi?CHR=10. The International Human
Genome Sequencing Consortium assemblies of the Hu-
man Genome sequence hosted by the NCBI http://
www.ncbi.nlm.nih.gov/genome/guide/human/
release_notes.html[43], including NCBI MapViewer
Builds 22, 25, 29 and 31 corresponding to releases of April
2001, August 2001, April 2002, and November 2002 re-
spectively, were additional sources of data complementa-
ry to our findings presented in Figure 1. Repeat sequences
were identified within the BAC end-sequences and in the
HPV6AI1 integration site using CENSOR http://www.gi-
rinst.org/Censor_Server.html prior to BLASTN homology
searches http://ncbi.nlm.nih.gov/BLAST.
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